Manufacturing of New Modalities: New Opportunities Come With New Challenges
Summary: A shift toward precision and personalized medicine is a growth driver in the pharmaceutical industry. Biologics and advanced modalities ranging from antibody-drug conjugates and mRNA-based drugs to cell and gene therapies contribute to this growth. However, these new modalities bring a new set of challenges for innovators striving to manufacture at sufficient scale to simultaneously meet market demand, high-quality standards, expected production cost and an acceptable ROI. Dr. Mahdavi’s talk will review key growth areas, innovative technologies and future strategies designed to increase the efficiency and scalability of these advanced therapeutics.